143 related articles for article (PubMed ID: 33407950)
1. Mobile telephone delivered contingency management for encouraging adherence to supervised methadone consumption: feasibility study for an RCT of clinical and cost-effectiveness (TIES).
Metrebian N; Carr E; Goldsmith K; Weaver T; Pilling S; Shearer J; Woolston-Thomas K; Tas B; Cooper C; Getty CA; van der Waal R; Kelleher M; Finch E; Bijral P; Taylor D; Scott J; Strang J
Pilot Feasibility Stud; 2021 Jan; 7(1):14. PubMed ID: 33407950
[TBL] [Abstract][Full Text] [Related]
2. Telephone delivered incentives for encouraging adherence to supervised methadone consumption (TIES): Study protocol for a feasibility study for an RCT of clinical and cost effectiveness.
Metrebian N; Weaver T; Pilling S; Goldsmith K; Carr E; Shearer J; Woolston-Thomas K; Tas B; Getty CA; Cooper C; van der Waal R; Kelleher M; Finch E; Bijral P; Taylor D; Scott J; Strang J
Contemp Clin Trials Commun; 2020 Mar; 17():100506. PubMed ID: 31909291
[TBL] [Abstract][Full Text] [Related]
3. Using a pragmatically adapted, low-cost contingency management intervention to promote heroin abstinence in individuals undergoing treatment for heroin use disorder in UK drug services (PRAISE): a cluster randomised trial.
Metrebian N; Weaver T; Goldsmith K; Pilling S; Hellier J; Pickles A; Shearer J; Byford S; Mitcheson L; Bijral P; Bogdan N; Bowden-Jones O; Day E; Dunn J; Glasper A; Finch E; Forshall S; Akhtar S; Bajaria J; Bennett C; Bishop E; Charles V; Davey C; Desai R; Goodfellow C; Haque F; Little N; McKechnie H; Mosler F; Morris J; Mutz J; Pauli R; Poovendran D; Phillips E; Strang J;
BMJ Open; 2021 Jul; 11(7):e046371. PubMed ID: 34210725
[TBL] [Abstract][Full Text] [Related]
4. Positive reinforcement targeting abstinence in substance misuse (PRAISe): Study protocol for a Cluster RCT & process evaluation of contingency management.
Metrebian N; Weaver T; Pilling S; Hellier J; Byford S; Shearer J; Mitcheson L; Astbury M; Bijral P; Bogdan N; Bowden-Jones O; Day E; Dunn J; Finch E; Forshall S; Glasper A; Morse G; Akhtar S; Bajaria J; Bennett C; Bishop E; Charles V; Davey C; Desai R; Goodfellow C; Haque F; Little N; McKechnie H; Morris J; Mosler F; Mutz J; Pauli R; Poovendran D; Slater E; Strang J
Contemp Clin Trials; 2018 Aug; 71():124-132. PubMed ID: 29908336
[TBL] [Abstract][Full Text] [Related]
5. Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial.
Wu LT; John WS; Morse ED; Adkins S; Pippin J; Brooner RK; Schwartz RP
Addiction; 2022 Feb; 117(2):444-456. PubMed ID: 34286886
[TBL] [Abstract][Full Text] [Related]
6. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.
Connock M; Juarez-Garcia A; Jowett S; Frew E; Liu Z; Taylor RJ; Fry-Smith A; Day E; Lintzeris N; Roberts T; Burls A; Taylor RS
Health Technol Assess; 2007 Mar; 11(9):1-171, iii-iv. PubMed ID: 17313907
[TBL] [Abstract][Full Text] [Related]
7. Suboxone Treatment and Recovery Trial (STAR-T): Study Protocol for a Randomised Controlled Trial of Opioid Medication Assisted Treatment with Adjunctive Medication Management Using Therapeutic Drug Monitoring and Contingency Management.
Elarabi H; Elrasheed A; Ali A; Shawky M; Hasan N; Gawad TA; Adem A; Marsden J
J Addict; 2019; 2019():2491063. PubMed ID: 30956839
[TBL] [Abstract][Full Text] [Related]
8. The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale.
Socias ME; Ahamad K; Le Foll B; Lim R; Bruneau J; Fischer B; Wild TC; Wood E; Jutras-Aswad D
Contemp Clin Trials; 2018 Jun; 69():21-27. PubMed ID: 29627621
[TBL] [Abstract][Full Text] [Related]
9. MySafeRx: a mobile technology platform integrating motivational coaching, adherence monitoring, and electronic pill dispensing for enhancing buprenorphine/naloxone adherence during opioid use disorder treatment: a pilot study.
Schuman-Olivier Z; Borodovsky JT; Steinkamp J; Munir Q; Butler K; Greene MA; Goldblatt J; Xie HY; Marsch LA
Addict Sci Clin Pract; 2018 Sep; 13(1):21. PubMed ID: 30249279
[TBL] [Abstract][Full Text] [Related]
10. A pilot randomised controlled trial of brief versus twice weekly versus standard supervised consumption in patients on opiate maintenance treatment.
Holland R; Matheson C; Anthony G; Roberts K; Priyardarshi S; Macrae A; Whitelaw E; Appavoo S; Bond C
Drug Alcohol Rev; 2012 Jun; 31(4):483-91. PubMed ID: 22150819
[TBL] [Abstract][Full Text] [Related]
11. Mobile.net: Mobile Telephone Text Messages to Encourage Adherence to Medication and to Follow up With People With Psychosis: Methods and Protocol for a Multicenter Randomized Controlled Two-Armed Trial.
Välimäki M; Hätönen H; Adams CE
JMIR Res Protoc; 2012 Aug; 1(2):e8. PubMed ID: 23611874
[TBL] [Abstract][Full Text] [Related]
12. A non-randomised pilot study of the Solutions for Medication Adherence Problems (S-MAP) intervention in community pharmacies to support older adults adhere to multiple medications.
Patton DE; Pearce CJ; Cartwright M; Smith F; Cadogan CA; Ryan C; Clark E; Francis JJ; Hughes CM
Pilot Feasibility Stud; 2021 Jan; 7(1):18. PubMed ID: 33413650
[TBL] [Abstract][Full Text] [Related]
13. The Feasibility of a Using a Smart Button Mobile Health System to Self-Track Medication Adherence and Deliver Tailored Short Message Service Text Message Feedback.
Bartlett Ellis RJ; Hill JH; Kerley KD; Sinha A; Ganci A; Russell CL
JMIR Form Res; 2019 Jun; 3(2):e13558. PubMed ID: 31237568
[TBL] [Abstract][Full Text] [Related]
14. A qualitative exploration of patients' experience of mobile telephone-delivered contingency management to promote adherence to supervised methadone.
Getty CA; Weaver T; Metrebian N
Drug Alcohol Rev; 2023 Mar; 42(3):641-651. PubMed ID: 36269110
[TBL] [Abstract][Full Text] [Related]
15. Does training in motivational interviewing for community pharmacists improve outcomes for methadone patients? A cluster randomised controlled trial.
Jaffray M; Matheson C; Bond CM; Lee AJ; McLernon DJ; Johnstone A; Skea L; Davidson B
Int J Pharm Pract; 2014 Feb; 22(1):4-12. PubMed ID: 23822820
[TBL] [Abstract][Full Text] [Related]
16. A retrospective cohort study of medication dispensing at pharmacies: Administration matters!
Hesse M; Thylstrup B; Seid AK; Tjagvad C; Clausen T
Drug Alcohol Depend; 2021 Aug; 225():108792. PubMed ID: 34118551
[TBL] [Abstract][Full Text] [Related]
17. Text-message reminders to improve sunscreen use: a randomized, controlled trial using electronic monitoring.
Armstrong AW; Watson AJ; Makredes M; Frangos JE; Kimball AB; Kvedar JC
Arch Dermatol; 2009 Nov; 145(11):1230-6. PubMed ID: 19917951
[TBL] [Abstract][Full Text] [Related]
18. Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients.
Larance B; Degenhardt L; O'Brien S; Lintzeris N; Winstock A; Mattick RP; Bell J; Ali R
Drug Alcohol Rev; 2011 Nov; 30(6):613-20. PubMed ID: 21355939
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment.
Maas J; Barton G; Maskrey V; Pinto H; Holland R
Drug Alcohol Depend; 2013 Dec; 133(2):494-501. PubMed ID: 23962419
[TBL] [Abstract][Full Text] [Related]
20. Patient Feedback on a Mobile Medication Adherence App for Buprenorphine and Naloxone: Closed and Open-Ended Survey on Feasibility and Acceptability.
Smith CL; Keever A; Bowden T; Olson K; Rodin N; McDonell MG; Roll JM; Smoody G; LeBrun J; Miguel AQ; McPherson SM
JMIR Form Res; 2023 Apr; 7():e40437. PubMed ID: 37074780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
